BRIEF published on 10/23/2025 at 13:10, 1 year ago Medison Expands APAC Leadership with New Appointment APAC Expansion Medison Pharma Francis Wan Biopharmaceutical Leadership Breakthrough Therapies
BRIEF published on 10/23/2025 at 13:10, 1 year ago Medison renforce son leadership en Asie-Pacifique avec une nouvelle nomination Expansion En Asie-Pacifique Leadership Biopharmaceutique Medison Pharma Francis Wan Thérapies Révolutionnaires
PRESS RELEASE published on 10/23/2025 at 13:05, 1 year ago Medison Strengthens its Global Commercialization Platform, Appoints Francis Wan as VP, GM Asia Pacific Medison announces appointment of Francis Wan as VP, GM Asia Pacific to accelerate growth in the region and expand access to breakthrough therapies Biopharmaceutical Asia Pacific Francis Wan Medison Commercialization Platform
Published on 11/04/2026 at 23:10, 4 hours 55 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 5 hours 5 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 50 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 6 hours ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 03:55, 10 minutes ago AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Published on 11/05/2026 at 03:10, 55 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 4 hours 3 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 8 hours 24 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 8 hours 40 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:00, 10 hours 5 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 10 hours 5 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 10 hours 21 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
